Crossmark

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer

Crossref DOI link: https://doi.org/10.1186/s40425-019-0618-9

Published Online: 2019-05-22

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Adashek, Jacob J.

Junior, Pedro Nazareth Aguiar

Galanina, Natalie

Kurzrock, Razelle https://orcid.org/0000-0003-4110-1214
License Information

Text and Data Mining valid from 2019-05-22
More Information

Article History

Received: 20 February 2019

Accepted: 13 May 2019

First Online: 22 May 2019

Ethics approval and consent to participate

: n/a

: n/a

: JJA has no disclosures. RK has the following disclosure information: Stock and Other Equity Interests (IDbyDNA, CureMatch, Inc., and Soluventis); Consulting or Advisory Role (Gaido, LOXO, X-Biotech, Actuate Therapeutics, Roche, NeoMed, and Soluventis); Speaker’s fee (Roche); Research Funding (Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, Guardant Health, Grifols, Konica Minolta, and OmniSeq [All institutional]); Board Member (CureMatch, Inc). NG has no disclosures. PNA reports speaker fees from Merck, outside the submitted work.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.